How extended periods of suppressed utilization and a regulatory pause on record collection may influence plans' anticipated results next year.
How New Price Transparency Rules May Impact Payers and Providers
Immediate considerations for the industry.
Despite HHS movement mandating that hospitals estimate patients' bills early on, the thing is, healthcare's already pretty shoppable.
An analysis of annual premiums by federal poverty level.
Fourteen percent of physicians offer virtual visits. But a new CMS rule may make telehealth more commonplace.
A closer look at how fast change may happen, who could win (and lose), and how the next decade may unfold for incumbents and new market entrants.
Analysis on the potential effects of cost-sharing reduction payments and pass-through savings.
In light of breaking news, the pharma value chain is definitely ripe for disruption. Here's how health plans, employers, and drug companies can adjust to the new normal.
The impact of one proposal the US Senate is considering to fund CSR payments.
Perceptions of behavioral health are evolving. Here’s why a multi-faceted approach to behavioral health brings more value to patients.